Elekta to Deliver Brain Mapping Technology to Froedtert HospitalMarch 11, 2008
The MEG system will enable neurosurgeons, neurologists, and those in related fields to noninvasively and accurately record human brain activity in real time.
ATLANTA and MILWAUKEE /PRNewswire/ -- Elekta Neuromag, world-leading equipment for noninvasive measurement of brain activity using magnetoencephalography (MEG) technology, has been ordered by Froedtert Memorial Lutheran Hospital.
Located in the western suburbs of Milwaukee, Froedtert Hospital has played a critical role in the quality of life in Wisconsin and northern Illinois since opening its doors in 1980 as a not-for-profit hospital. More than 800 Medical College of Wisconsin physicians and more than 4000 staff members are dedicated to excellence in patient care, research, and medical education at this premier academic medical center.
Froedtert Hospital will receive its new Elekta Neuromag MEG system in the autumn of 2008. With the MEG system from Elekta installed, neurosurgeons, neurologists, and those in related fields will be able to noninvasively record human brain activity in real time, better and more accurately than ever before.
MEG technology is regarded as the most efficient method for tracking brain activity at millisecond resolution. Compared with EEG technology, MEG has uniquely accurate localization capabilities. Other technologies (e.g., computed tomography and magnetic resonance imaging, or MRI), provide only anatomical or metabolic information; whereas, MEG is a direct measure of neuronal electric activity. When complemented with MRI, MEG increases the ability to understand brain activity and to improve treatment of functional disorders and, in particular, epilepsy.
"We look forward to soon becoming the site of the first whole-head magnetoencephalography lab in the state," says Elizabeth Ragalie, Director of the Neurosciences Center at Froedtert Hospital. "We intend to use the MEG in our epilepsy program as a powerful new tool for pre-surgical planning. The noninvasive and fast measurement capability of the technology is well suited to the high-quality patient care and advancement of scientific discovery that we strive to achieve here at Froedtert." Ragalie went on to say, "Furthermore, we plan to launch an ambitious research program in conjunction with the Medical College of Wisconsin, which will make use of the unique temporal resolution of MEG technology. We chose the Elekta Neuromag MEG system because its combination of sensitive detectors, robust environmental noise cancellation, and versatile software was deemed best able to meet the stringent demands of our users."
"With leading technology to the development of MEG technology and methodology, Elekta was the natural choice when Froedtert made its decision," says Gordon Haid, Director of MEG Sales for North America. "We are pleased to see an increasing interest around the world for Elekta Neuromag systems, particularly in the U.S."
The Elekta Neuromag 306-channel MEG sensor array has a "higher density of detectors than any other system on the market," leading to a more accurate representation of brain activity. The industry's lowest signal-to-noise ratio means that more useful information is acquired, thus yielding the highest information per sample.
The unique design of the sensors combined with advanced software makes it possible to gain data with unsurpassed detail, even from the deepest regions of the brain. The system also has the highest available immunity to magnetic interference, either patient-related or external. Elekta Neuromag also has the lowest operational costs. "Elekta Neuromag is technically the most sophisticated MEG/EEG device available on the market today."
Elekta is an international medical technology group, providing oncologists, radiation therapists, neurosurgeons, and many other medical specialists with state-of-the-art tools to fight serious disease. Elekta provides advanced clinical solutions, comprehensive management and information systems, as well as services for improved cancer care and management of brain disorders. Elekta's systems and solutions are used in over 4500 hospitals around the world. Clinical and information management solutions include, among others, the Leksell Gamma Knife for noninvasive treatment of brain disorders, Elekta Axesse and Elekta Synergy for stereotactic and image-guided radiation therapy and radiosurgery, as well as the MOSAIQ suite of software for image-enabled EMR and efficient management of clinical and patient data.
With over 2000 employees globally, the corporate headquarter is located in Stockholm, Sweden.
Most Read Articles